Skip to content

Clinical trials

Phase 3 Muscular Diseases trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Muscular Diseases Phase: Phase 3 Country / region: Australia Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20131
20141
20171
20212
20221
20232
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Active, not recruiting2
Terminated2
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals3
PTC Therapeutics3
Avidity Biosciences, Inc.1
Calcilytix Therapeutics, Inc., a BridgeBio company1
Kyntra Bio1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Muscular Diseases9
Musculoskeletal Diseases6
Genetic Diseases, Inborn5
Muscular Disorders, Atrophic5
Muscular Dystrophies5
Muscular Dystrophy, Duchenne5
Nervous System Diseases5
Neuromuscular Diseases5
Genetic Diseases, X-Linked4
Bulbo-Spinal Atrophy, X-Linked3

Trials

Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.